NCT07020520View on ClinicalTrials.gov

EvaluatioN of Optilume Drug-Coated Balloon for the Endoscopic Treatment of UREteric Strictures

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

July 30, 2031

Conditions
Ureteral Stricture
Interventions
DEVICE

Optilume

Has pre-treatment (balloon dilation or ureterotomy) followed by paclitaxel-coated balloon (Optilume) treatment of the ureteric stricture.

Trial Locations (2)

32806

RECRUITING

Orlando Health, Orlando

92868

RECRUITING

University of California Irvine, Orange

Sponsors
All Listed Sponsors
collaborator

Laborie Medical Technologies Inc.

INDUSTRY

lead

Urotronic Inc.

INDUSTRY

NCT07020520 - EvaluatioN of Optilume Drug-Coated Balloon for the Endoscopic Treatment of UREteric Strictures | Biotech Hunter | Biotech Hunter